证券代码：920300 证券简称：辰光医疗 公告编号：2026-003 上海辰光医疗科技股份有限公司 关于召开 2026 年第一次临时股东会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 本次股东会的召集、召开符合《公司法》有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （四）会议召开方式 一、会议召开基本情况 （一）股东会届次 本次会议为 2026 年第一次临时股东会。 （二）召集人 本次股东会的召集人为董事会。 上海辰光医疗科技股份有限公司（以下简称"公司"）于 2026 年 1 月 3 日 召开第五届董事会第二十五次会议，审议通过了《关于召开 2026 年第一次临时 股东会通知的议案》。 （三）会议召开的合法合规性 本次会议采用现场投票和网络投票相结合方式召开。 公司股东应选择现场投票、网络投票中的一种方式，如果同一表决权出现 重复投票表决的，以第一次投票表决结果为准。 （五）会议召开日期和时间 1、现场会议召开时间：2026 年 1 月 20 日下午 ...

上海辰光医疗科技股份有限公司 第五届董事会第二十五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2026 年 1 月 3 日 2.会议召开地点：上海市青浦区华青路 1269 号 3.会议召开方式：现场会议 证券代码：920300 证券简称：辰光医疗 公告编号：2026-001 4.发出董事会会议通知的时间和方式：2025 年 12 月 26 日以书面、电话和微 信方式发出 5.会议主持人：董事长 王杰 先生 6.会议列席人员：高级管理人员 7.召开情况合法合规的说明： 会议的召集、召开和表决程序符合有关法律、行政法规、规范性文件和《公 司章程》的规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 二、议案审议情况 （一）审议通过《关于公司拟向招商银行股份有限公司上海分行申请并使用授信 额度的议案》 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票；回避 2 票。 本议案已经公司第五届董 ...

证券代码：920300 证券简称：辰光医疗 公告编号：2026-002 上海辰光医疗科技股份有限公司 关联交易公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、关联交易概述 （一）关联交易概述 上海辰光医疗科技股份有限公司（以下简称"公司"）拟向招商银行股份 有限公司上海分行申请并使用人民币 3,000 万元的综合授信，期限为 12 个月， 用于补充流动资金。公司控股股东及实际控制人王杰提供连带责任保证担保。 在实际贷款业务发生时，具体授信事宜以招商银行相关协议为准。 董事会授权公司董事长王杰先生代表本公司办理上述信贷事宜并签署有 关合同和文件。 （二）决策与审议程序 本次关联交易经公司第五届董事会第二十五次会议审议通过，并已按照 《公司章程》相关规定王杰先生及左永生先生执行了回避表决，本议案尚需提 交公司 2026 年第一次临时股东会审议。 上述议案已经公司第五届董事会独立董事专门会议审议通过，独立董事一 致同意并将该议案提交董事会审议。 （三）本次关联交易不存在需经有关部门批准的情况 二、关 ...

Group 1 - The core point of the article is that Changuang Medical (920300) was featured on the trading leaderboard due to a significant trading volume and turnover rate on January 5, 2026, with a turnover rate of 24.13% and a transaction amount of 275 million yuan [1][3]. - The total number of shares traded for Changuang Medical on that day was approximately 16.06 million shares [1]. - The leading buyer was an institutional investor, purchasing approximately 6.28 million yuan worth of shares, while the main seller was CITIC Securities, selling around 5.45 million yuan [1][2]. Group 2 - The trading data shows that the top three buying institutions included Dongfang Securities and Guotou Securities, with buying amounts of approximately 6.15 million yuan and 4.91 million yuan, respectively [2]. - The selling data indicates that the top three selling institutions were CITIC Securities, Jianghai Securities, and Guojin Securities, with selling amounts of approximately 5.45 million yuan, 5.43 million yuan, and 5.24 million yuan, respectively [2]. - The overall trading activity reflects a high level of interest in Changuang Medical, as evidenced by the substantial turnover and participation from both institutional buyers and sellers [1][2].

Core Viewpoint - The A-share market is experiencing a localized surge in the controlled nuclear fusion concept, with notable stocks such as Wangzi New Materials hitting the daily limit up and Libet approaching the limit up [1] Group 1: Market Performance - Wangzi New Materials has reached the daily limit up, indicating strong investor interest [1] - Libet has seen significant price movement, nearing the daily limit up [1] - Other companies such as Guoguang Electric, Guoji Heavy Industry, Hezhuan Intelligent, Changfu Shares, and Chenguang Medical are also experiencing upward trends [1] Group 2: Industry Outlook - The 2026 Nuclear Fusion Energy Technology and Industry Conference is scheduled to take place from January 16 to 17, 2026, in Hefei, Anhui [1] - According to a report by Zheshang Securities, the global nuclear fusion equipment market is expected to reach an average annual scale of 266 billion yuan by 2035 [1]

国内动态：发改委发文加快构建现代化基础设施体系，BEST订单持续释放 12月25日，国家发改委基础设施发展司发布文章《加快构建现代化基础设施体系》，提出加大长时储 能、绿电制氢氨醇、核聚变等技术攻关。近期等离子体所、聚变新能发布/更新多项采购，前期招标的 氚工厂、低温系统等核心部件已陆续开标并公示中标情况。中国工程物理研究院(原简称"九院")材料研 究所中标等离子所氚增殖系统全部4个项目合计约11.4亿元。合肥物质科学研究院预中标低温系统关键 部件(预算7.28亿元);合肥物质科学研究院等联合体获BEST装置TF磁体项目8.885亿元;西部超导、上海超 导获千万级订单。 智通财经APP获悉，开源证券发布研报称，可控核聚变装置研发建设稳步推进，BEST、星火一号、先 觉聚能、环流四号项目有望陆续开工，核心部件订单有望持续释放;TMTG并购TAE打造全球首家商业聚 变上市公司，有望提振FRC板块情绪;Helion曾官宣将于2025年内实现发电验证，若FRC技术路线工程可 行性得到验证，国内相关初创公司项目有望加速推进;十五五规划建议前瞻布局核聚变能领域;该行看好 板块长期发展前景，建议关注磁体、主机和电源等核心部 ...

Core Viewpoint - The company Jianxin Superconductor (688805.SH) has successfully launched on the STAR Market, focusing on the research, production, and sales of core components for medical MRI equipment, which constitute approximately 50% of the cost of MRI devices [1][4]. Group 1: Company Overview - Jianxin Superconductor was established on December 11, 2013, and is recognized as one of the earliest manufacturers in China to scale the production of high-field superconducting magnets [7]. - The company has developed a diverse product matrix, including 1.5T and 3.0T superconducting magnets, and is the largest independent supplier of superconducting magnets globally [7]. - Jianxin Superconductor has established strong partnerships with renowned MRI equipment manufacturers such as Fujifilm, GE Healthcare, and others, facilitating the global promotion of MRI devices [7]. Group 2: Financial Metrics - The IPO price was set at 18.58 CNY per share, with an institutional offering price of 18.89 CNY per share, resulting in a market capitalization of 3.115 billion CNY [4]. - The company’s earnings per share (EPS) is projected with a price-to-earnings (P/E) ratio of 61.97, compared to the industry average of 31.79 [4]. Group 3: Fundraising and Investment Plans - Jianxin Superconductor plans to invest raised funds in several projects, including a 600-unit production line for liquid helium-free superconducting magnets (2.75 billion CNY), a technical upgrade for high-field superconducting magnets (2.60 billion CNY), and the development of new superconducting magnets (2.40 billion CNY) [6]. Group 4: Market Risks - The company faces a high customer concentration risk, with the top five customers accounting for 73.75% to 83.43% of total revenue from 2022 to mid-2025, with Fujifilm being the largest customer [8].

Group 1 - The controllable nuclear fusion sector is experiencing strong growth, with companies like Western Materials reaching new highs and several others, including Wangzi New Materials and Xue Ren Group, hitting the daily limit up [1] - The domestic production rate of key nuclear fusion equipment has exceeded 96%, with critical components like tungsten-based divertors and high-temperature superconducting tapes now being produced independently [1] - The industry is entering a new phase characterized by multiple competitive technological routes and concentrated capital investment, driven by advancements in the BEST device and EAST's long-pulse operation records [2] Group 2 - The nuclear fusion industry is progressing from experimental verification to engineering demonstration, with a clear three-step development plan: experimental pile, demonstration pile, and commercial pile, aiming for completion of the experimental pile by 2035 and commercial demonstration by 2050 [5] - AI technology is playing a significant role in accelerating the commercialization of nuclear fusion, optimizing reaction conditions, and predicting plasma behavior, which enhances the stability and efficiency of fusion reactions [8][13] - Material innovation is crucial for overcoming bottlenecks in the nuclear fusion industry, focusing on surface and structural innovations, optimizing superconducting materials, and enhancing material properties through modification [15][17] Group 3 - Leading companies in the energy equipment sector have made significant progress in the development of core components for nuclear fusion, with a clear path to industrialization and ongoing benefits in sub-sectors like superconductors and divertor materials [23][25] - Four Creation Electronics is the only domestic company to achieve the localization of superconducting magnet power supply modules for fusion devices, securing a significant market position [26][27] - An Tai Technology is a global supplier of core components for controllable nuclear fusion devices, providing a range of products that support various nuclear power technologies [30]

| | | | | | | | 早1V: 月九 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 项目 | 2025年1-6月 | | 2024 年度 | | 2023 年度 | | 2022 年度 | | | | 要领 | 片比 | 金额 | 早 | 金额 | 早出 | 金额 | 早 | | 超导产品 | 17,430.63 | 73.17% | 26,324.00 | 65.58% | 26,289.61 | 62.26% | 18,185.33 | 54.82% | | 其中:零挥发 超导产品 | 12.171.03 | 51.09% | 21.211.13 | 52.84% | 23.983.89 | 56.80% | 16,959.36 | 51.12% | | 无液氮超导 产品 | 5,171.90 | 21.71% | 4.924.81 | 12.27% | 2,077.00 | 4.92% | 1,007.45 | 3.04% | | 永磁产品 | 6,389.92 | 26.83% | 13,817.74 | 34.4 ...

Core Insights - The controllable nuclear fusion sector is experiencing significant market activity, with multiple stocks reaching their daily limit up, driven by the commercial potential of nuclear fusion technology [1] - The International Energy Agency predicts that the global nuclear fusion market could approach $500 billion by 2030, approximately 3.5 trillion yuan, highlighting the accelerating trend of nuclear fusion technology moving from laboratory to commercial application [1] Sector Analysis - **Superconducting Materials Sector**: The demand for high-performance superconducting materials is expected to rise as controllable nuclear fusion devices require strong magnetic fields, providing growth opportunities for related companies [2] - **Core Component Manufacturing Sector**: The precision manufacturing of core components like vacuum chambers and dewars is critical, and the initiation of various fusion projects will lead to increased orders for companies with advanced manufacturing capabilities [2] - **Power Equipment Sector**: Companies specializing in high-performance power supply systems for magnetic fields and heating will see demand growth as the industry develops, opening up market opportunities [2] Key Company Highlights - **Snowman Group**: Achieved two consecutive limit-up days, becoming one of the leading stocks in the sector, with business alignment and technical reserves that attract market attention [3] - **Hezhong Intelligent**: Involved in the development of vacuum chambers for fusion devices, benefiting from the sector's growth due to its strong background in high-end equipment manufacturing [3] - **Western Superconducting Technologies**: A leading domestic producer of superconducting materials, has developed engineering production technology for NbTi superconducting wire used in fusion projects, contributing to its stock performance [3] - **Aikesaibo**: Provides critical support services for magnetic and heating power supplies in fusion projects, with applications in several national projects, resulting in a stock increase of over 11% [3]